1-3 of 3
Joseph M Unger, Ph.D.
Close
Sort by
Journal Articles

A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy Plus Rituximab Vs. CHOP Chemotherapy Plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphoma

Oliver W. Press, MD, PhD, Joseph M Unger, Ph.D., Lisa M. Rimsza, MD, Jonathan Friedberg, MD, Michael LeBlanc, Ph.D., Myron S. Czuczman, MD, Mark S. Kaminski, MD, Rita M. Braziel, MD, David G. Maloney, MD, PhD, Bruce D. Cheson, MD, Thomas P. Miller, MD, Richard I Fisher, MD
Journal: Blood
Blood (2011) 118 (21): 98.
https://doi.org/10.1182/blood.V118.21.98.98
Published: 2011
Journal Articles

R-CHOP with Iodine-131 Tositumomab Consolidation for Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL): Southwest Oncology Group Protocol S0433

Jonathan W. Friedberg, MD, Joseph M Unger, Ph.D., W. Richard Burack, Ajay K Gopal, MD, Michael LeBlanc, Ph.D., Oliver W. Press, MD, PhD, Thomas P. Miller, MD, Richard I Fisher, MD
Journal: Blood
Blood (2010) 116 (21): 590.
https://doi.org/10.1182/blood.V116.21.590.590
Published: 2010
Journal Articles

Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab (R-CHOP) Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell (DLBCL) NHL: Southwest Oncology Group Study S0515

Alison T. Stopeck, MD, Joseph M Unger, Ph.D., Lisa M. Rimsza, MD, Brent Farnsworth, DO, Michael LeBlanc, Ph.D., Maria Iannone, MS, Richard I Fisher, MD, Thomas P. Miller, MD
Journal: Blood
Blood (2010) 116 (21): 591.
https://doi.org/10.1182/blood.V116.21.591.591
Published: 2010